← Eichor
Condition: Early Breast Cancer Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Early Breast Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer
Phase 4 · 34 location(s) · Fudan University · NCT04790305Mediterranean Diet and Inequality in Early Breast Cancer
Phase 2 · 2 location(s) · Esbjerg Hospital - University Hospital of Southern Denmark · NCT07007169SABER Study for Selected Early Stage Breast Cancer
NA · 1 location(s) · University of Miami · NCT04360330NEOadjuvant Abemaciclib and GIredestrant TriaL in Patients with ER-positive, HER2-negative Early Breast Cancer
Phase 2 · 8 location(s) · Fondazione Oncotech · NCT06259929Dietary Habits, Nutritional Knowledge and Physical Activity Assessment in Early Stage Breast Cancer Patients
Phase N/A · 1 location(s) · Centro di Riferimento Oncologico - Aviano · NCT06073418Neoadjuvant Therapy Study Guided by Drug Screening in Vitro for Human Epidermal Growth Factor Receptor 2 (HER2) Negative
Phase 1/Phase 2 · 1 location(s) · Peking University People's Hospital · NCT04836156A Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Giredestrant in Participants With ER+/HER2-
Phase 3 · 1 location(s) · Genentech, Inc. · NCT07541079Dalpiciclib With or Without Entinostat and Letrozole in HR+/HER2- Early Breast Cancer
Phase 2 · 1 location(s) · Hebei Medical University Fourth Hospital · NCT07492394EXoPERT EMERALD Clinical Study
Phase N/A · 9 location(s) · EXoPERT · NCT07186296Neoadjuvant Camrelizumab and Fluzoparib and Nab-paclitaxel in Early Breast Cancer With HRR Gene Mutation
Phase 2 · 1 location(s) · Ying Lin · NCT05761470Intratumoral INT230-6 Followed by Neoadjuvant Immuno-chemotherapy in Patients With Early TNBC. INVINCIBLE-4-SAKK
Phase 2 · 9 location(s) · Swiss Cancer Institute · NCT06358573Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative
Phase 2 · 3 location(s) · City of Hope Medical Center · NCT06042569Immunotherapy-related CRP Kinetics in Early and Metastatic Triple-negative Breast Cancer
Phase N/A · 1 location(s) · University Hospital Tuebingen · NCT05914961Study of Molecular Characterisation of Early Operable Primary Breast Cancer in Pakistani Population
Phase N/A · 1 location(s) · Liaquat University of Medical & Health Sciences · NCT06830590Adjuvant Therapy for Intermediate Risk HER2 Positive, Lymph Node Negative Early Breast Cancer With Chemotherapy Combined
Phase N/A · 1 location(s) · Shu Wang · NCT06711068A Registry Study of Breast Microseed Treatment
Phase N/A · 3 location(s) · Concure Oncology-Breast Microseed Inc. · NCT02701244A Study to Test Inavolisib Treatments in Participants With Early-Stage, PIK3CA-Mutated Breast Cancer
Phase 2 · 33 location(s) · Hoffmann-La Roche · NCT07054190SBRT in Early Breast Cancer in Elderly Women
NA · 1 location(s) · University of Rome Tor Vergata · NCT05071105RAGE Inhibition to Decrease Cardiotoxicity in Women With Early Breast Cancer
Phase 1/Phase 2 · 3 location(s) · Georgetown University · NCT05256745Patient Relevant Outcomes Improvement Program in High Risk Hormone Receptor Positive (HR+) Breast Cancer
Phase N/A · 1 location(s) · Institut fuer Frauengesundheit · NCT07531693CDK4/6 Inhibitors Combined With Standard Adjuvant Endocrine Therapy in High-Risk, HR+/HER2+ Early Breast Cancer Patients
Phase 3 · 1 location(s) · Fudan University · NCT07019363Chronic Toxicities Related to Treatment in Patients With Localized Cancer
NA · 1 location(s) · UNICANCER · NCT01993498Endoscopy/Robotic Assisted Nipple Skin Sparing Mastectomy
Phase N/A · 1 location(s) · Alejandra García-Novoa · NCT06823414A Prospective, Multicenter Registry to Observe the Treatment Patterns, Clinical Outcomes, and Decision-Making in Patient
Phase N/A · 13 location(s) · National and Kapodistrian University of Athens · NCT07389408A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in
Phase N/A · 284 location(s) · Novartis Pharmaceuticals · NCT06830720Omission of SLNB in CN0 Early Breast Cancer
NA · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT05935150NEODOXy: Targeting Breast Cancer Stem Cells With Doxycycline
Phase 2 · 8 location(s) · Swiss Cancer Institute · NCT06452394Neoadjuvant Therapy Study Guided by Drug Screening in Vitro for HER2 Positive Early Breast Cancer Patients
Phase 1/Phase 2 · 1 location(s) · Peking University People's Hospital · NCT04750122MELIORA Data Collection Campaigns
NA · 7 location(s) · Harokopio University · NCT07190066A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
Phase 3 · 709 location(s) · AstraZeneca · NCT05774951
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.